In fact, we demonstrate that the reduced number of CD161-expressing T cells could be seen as an independent predictor of GVHD, and that CCR6+CD161-expressing T cells may be involved in the immune pathology of GVHD following their CCL20-dependent recruitment into affected tissues. Here, CCL20 is linked to graft versus host disease.